Chronic myeloid leukemia (CML) is a stem cell-derived hematological malignancy with genomic aberrations appearing in hematopoietic stem and progenitor cells characterized by a fusion oncogene BCR/ABL. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.